FDA approves weight-loss drug Zepbound for obstructive sleep apnea

The U.S. Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the weight-loss drug Zepbound.

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts